title: Cervical cancer screening.
abstract: These NCCN Guidelines Insights focus on recent recommendations for cervical cancer screening and management of abnormal screening tests. When the NCCN Panel convened to update the NCCN Guidelines for Cervical Cancer Screening, they decided to adopt and endorse guidelines from other organizations to avoid duplication of effort. Therefore, in July 2013, after review and validation of consensus guidelines from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology, the NCCN Guidelines for Cervical Cancer Screening were discontinued.
authors.affiliation: From 1University of Alabama at Birmingham Comprehensive Cancer Center; 2Memorial Sloan-Kettering Cancer Center; 3Moffitt Cancer Center; 4Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; and 5National Comprehensive Cancer Network.
authors.forename: Edward E
authors.initials: EE
authors.lastname: Partridge
authors.forename: Nadeem
authors.initials: N
authors.lastname: Abu-Rustum
authors.forename: Anna
authors.initials: A
authors.lastname: Giuliano
authors.forename: Stewart
authors.initials: S
authors.lastname: Massad
authors.forename: Joan
authors.initials: J
authors.lastname: McClure
authors.forename: Mary
authors.initials: M
authors.lastname: Dwyer
authors.forename: Miranda
authors.initials: M
authors.lastname: Hughes
mesh_terms: D055088:Early Detection of Cancer / Q000379:methods; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*